血栓通辅助依达拉奉治疗缺血性脑卒中的可行性分析

Feasibility analysis of Thrombosis assisted Edaravone in treating ischemic stroke

目的:研究血栓通辅助依达拉奉治疗缺血性脑卒中患者的临床效果,以探讨此疗法在临床应用上是否可行。方法:选择80例缺血性脑卒中患者为研究对象,将其随机分为对照组和实验组各40例,对照组单独应用依达拉奉治疗,实验组用血栓通辅助依达拉奉联合治疗。观察比较两组患者的临床疗效以及治疗前后的神经功能缺损情况。结果:实验组患者经治疗后总有效率为95.00%,明显高于对照组的70.00%,差异有统计学意义(P<0.05);治疗后两组的神经功能缺损情况均有显著改善,且实验组的改善程度比对照组好,差异有统计学意义(P<0.05)。结论:血栓通辅助依达拉奉治疗缺血性脑卒中患者具有很好的临床效果,能有效改善患者的神经功能缺损。

Objective： To study the clinical effect of Thrombosis assisted Edaravone in the treatment of ischemie stroke patients to explore whether this therapy is feasible in clinical application. Methods：A total of 80 patients with ischemic stroke were randomly divided into control group and experimental group, forty patients in each group. The control group was treated with Edaravone alone, and the experimental group was treated with Thrombosis assisted Edaravone. The clinical efficacy of the two groups was observed and the neurological deficits before and after treatment were observed. Results：The total effective rate of the patients in the experimental group was 95.00%, which was significantly higher than that of the control group （70.00%）, the difference was statistically significant（P〈0.05）. After treatment, the neurological deficits of the two groups were significantly improved. The improvement of the experimental group was significantly better than the control group, the difference was statistically significant （P〈0.05）. Conclusion ：Thrombosis assisted Edaravone in the treatment of patients with ischemic stroke has a good clinical effect, can effectively improve the patient＇s neurological deficits.